Evidence map›Paper›PMID 42812617›Full record

ArticleFrontiers in artificial intelligence2026

Imaging-based development and validation of artificial intelligence models for lung adenocarcinoma precursor lesions and early lung adenocarcinoma presenting as pulmonary nodules.

Junbao Zhang, Yanyi Hou, Yikang Yang, Ziyan Zhang, Yi Gao, Ping Xu

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Junbao Zhang *Department of Pulmonary and Critical Care Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Yanyi Hou *Department of Pulmonary and Critical Care Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
Yikang Yang *Shenzhen University Medical School, Shenzhen, China.
Ziyan ZhangDepartment of Radiotherapy Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Yi GaoShenzhen University Medical School, Shenzhen, China.
Ping XuDepartment of Pulmonary and Critical Care Medicine, Peking University Shenzhen Hospital, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accurate preoperative assessment of pulmonary nodule invasiveness remains challenging. We developed an internally validated multimodal framework integrating CT representations from a frozen vision foundation model with clinical variables. Methods: This retrospective single-centre study included 1,179 pathologically confirmed pulmonary nodules: 247 glandular precursor lesions comprising atypical adenomatous hyperplasia and adenocarcinoma Results: The held-out test-fold AUCs were 0.848, 0.864, 0.867, 0.882, and 0.822, yielding a mean AUC of 0.8566. Pooled out-of-fold predictions produced an AUC of 0.847, accuracy of 0.809, sensitivity of 0.806, specificity of 0.822, and F1 score of 0.873. DINOv3 and NCART achieved the highest point-estimate AUCs among the evaluated feature extractors and classifiers, respectively, although most pairwise differences were not statistically significant. Intermediate fusion significantly outperformed the Gould score and the clinical-data-only model, but not the imaging-only or late-fusion models. In the prespecified secondary analysis, the model achieved an AUC of 0.780 for distinguishing adenocarcinoma Conclusion: The proposed framework achieved internally validated discrimination of pulmonary nodule invasiveness. External multicentre and prospective validation is required before clinical implementation.

Indexed as

DINOv3invasiveness predictionlung adenocarcinomamultimodal learningpulmonary nodules

Identifiers

PMID42812617
PMCPMC13619932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.